Publications

The homestasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients.  (2011)

Authors:
Fattovich, Giovanna; Covolo, L; Pasino, Michela; Perini, E; Rossi, L; Brocco, Giorgio; Guido, M; Cristofori, C; Belotti, C; Puoti, M; Gaeta, Gb; Santantonio, T; Raimondo, G; Bruno, R; Minola, E; Negro, F; Donato, F; Italian Hepatitis C., Cohort Study Collaborative Group
Title:
The homestasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients.
Year:
2011
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Format:
A Stampa
Referee:
Name of journal:
LIVER INTERNATIONAL
ISSN of journal:
1478-3223
N° Volume:
31
Number or Folder:
1
Page numbers:
66-74
Keyword:
insulin resistance; hepatitis C; antiviral therapy
Short description of contents:
OBJECTIVES: To investigate the independent association between the homeostasis model assessment of the insulin resistance (HOMA-IR) score and rapid virological response (RVR) and sustained virological response (SVR) in chronic hepatitis C (CHC). METHODS: Observational prospective cohort study of 412 CHC patients [59% males; mean age 45 years; genotype 1 (44%), 2 (32%), 3 (19%) and 4 (5%)] treated with pegylated interferon α plus ribavirin. RESULTS: A HOMA-IR ≥2.0 was present in 49% and a metabolic syndrome in 4% of patients. By multivariate analysis, independent predictors of SVR were the lack of advanced fibrosis (≥F3) in genotype 1 and a lower body mass index in genotype 3 patients. In the subgroup of patients in whom HCV-RNA was evaluated at week 4 (n = 281), independent predictors of RVR were HCV-RNA <700,000 IU/ml, age <40 years and lower aspartate aminotransferase:alanine aminotransferase ratio in genotype 1 and baseline HOMA-IR ≤2 in genotype 3 patients. No predictive factor of RVR was identified among genotype 2 patients. RVR was the strongest predictor of SVR among genotype 1 or 3 patients. CONCLUSIONS: In this series of treatment-naïve, Caucasian CHC patients at a low risk for the metabolic syndrome, HOMA-IR is not a predictor of SVR, irrespective of the HCV genotype, although it may predict RVR in genotype 3 infection.
Note:
Comment in Insulin resistance and sustained virological response in hepatitis C: from bench to bedside. [Liver Int. 2011]
Product ID:
59048
Handle IRIS:
11562/346055
Deposited On:
February 10, 2011
Last Modified:
November 15, 2022
Bibliographic citation:
Fattovich, Giovanna; Covolo, L; Pasino, Michela; Perini, E; Rossi, L; Brocco, Giorgio; Guido, M; Cristofori, C; Belotti, C; Puoti, M; Gaeta, Gb; Santantonio, T; Raimondo, G; Bruno, R; Minola, E; Negro, F; Donato, F; Italian Hepatitis C., Cohort Study Collaborative Group, The homestasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients. «LIVER INTERNATIONAL» , vol. 31 , n. 12011pp. 66-74

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

Related projects
Title Department Managers
Studio osservazionale multicentrico per la valutazione dei fattori che influenzano efficacia, tolleranza ed adesione al trattamento con interferone peghilato e ribavirina dei pazienti con epatite cronica da HCV nella pratica clinica corrente. Department Medicina Giovanna Fattovich
<<back

Activities

Research facilities

Share